- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04120948
Laser Tongue Debridement for Oral Malodor
Malodor is a multifactorial condition with oral pathology representing the main culprit and the tongue being the first to second contributor to the malodor. Bacterial load can represent a quantifiable measure regardless of the original pathology. It is hypothesized that reduction in malodor can be represented by tongue changes both in appearance, bacterial and biofilm load reduction (measured by CFU and volatile gases measurement), organoleptic measurement and subjective improvement.
Methods: A randomized controlled prospective study under IRB approval. Diagnostic criteria for enrollment and follow up were organoleptic test by 2 judges, halimeter reading, tongue colores changes HALT questionnaire and direct aerobic and anaerobic tongue cultures measured by CFU. Patients were treated with laser tongue debridement (LTD) with an Er,Cr:YSGG solid state laser has been shown to be effective in biofilm reduction.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10019
- New York Head & Neck Institute offices
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- an individual (male or female) who can understand and voluntarily sign an informed consent form
- a baseline organoleptic oral malodor score of at least 2
Exclusion Criteria:
- severe caries,
- signs of gingival inflammation on intraoral exam
- possible extra-oral halitosis (tonsillitis, sinusitis, and pulmonary pathologic conditions, or a condition that may contribute to systemic halitosis, such as hepatic cirrhosis or uncontrolled diabetes)
- antibiotic treatment within 1 month prior to study
- pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Waterlase Express Laser System
10-minute treatment with the Waterlase Express (Biolase, Irvine CA).
The dorso-posterior surface of the tongue is treated with the laser in 10 passes of 60 seconds each with 10 seconds of rest in between.
Laser settings were 60μs pulse width, 4W, 40Hz, 10% air and 5% water irrigation.
An MC12 sapphire laser tip (Biolase, Irvine CA) is held 3mm away from the tongue in a constant sweeping motion during treatment with passes overlapping passes in alternate direction, side to side motion and front to back motion with laser fluence on the tongue surface calculated at 3J/cm2.
The settings were non ablative and non thermal.
|
10-minute treatment with the Waterlase Express (Biolase, Irvine CA).
The dorso-posterior surface of the tongue is treated with the laser in 10 passes of 60 seconds each with 10 seconds of rest in between.
Laser settings were 60μs pulse width, 4W, 40Hz, 10% air and 5% water irrigation.
An MC12 sapphire laser tip (Biolase, Irvine CA) is held 3mm away from the tongue in a constant sweeping motion during treatment with passes overlapping passes in alternate direction, side to side motion and front to back motion with laser fluence on the tongue surface calculated at 3J/cm2.
The settings were non ablative and non thermal.
|
|
Active Comparator: Tongue scraper
tongue scraping
|
mechanical scraping of the dorso-posterior surface of the tongue
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Halimeter measurement
Time Frame: change from baseline to 1 month
|
Measurement of volatile sulfur compounds in patient's breath.
|
change from baseline to 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HALT questionnaire
Time Frame: change from baseline to 1 month
|
Quality of life (QOL) questionnaire that ranks responses.
The total score is evaluated on a scale of 0-100.
A score of 0 correlates to no perceived effect on QOL, and a score of 100 correlates to a severe perceived effect on QOL.
|
change from baseline to 1 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
bacterial load
Time Frame: change from baseline to 1 month
|
Sample is collected from the dorsal tongue surface.
Total anaerobic and aerobic bacterial colonies are counted (CFU).
|
change from baseline to 1 month
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NY Head and Neck
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Halitosis
-
Hadassah Medical OrganizationCompleted
-
Çankırı Karatekin UniversityCompleted
-
Church & Dwight Company, Inc.CompletedOral Malodor (Halitosis)United States
-
University of Nove de JulhoCompleted
-
University of British ColumbiaWithdrawn
-
Tokyo Medical and Dental UniversityCompleted
-
Universitaire Ziekenhuizen KU LeuvenGaba International AGUnknown
-
Tokyo Medical and Dental UniversityCompleted
Clinical Trials on Waterlase Express Laser System
-
University of PennsylvaniaTerminatedEndodontic Disease | Root Canal InfectionUnited States
-
Near East University, TurkeyCompletedStomatitis, Aphthous
-
Guy's and St Thomas' NHS Foundation TrustNot yet recruitingPeriodontitis
-
Hacettepe UniversityActive, not recruiting
-
VivaQuantCompletedAtrial Fibrillation (Paroxysmal) | Obstructive Sleep Apnea (OSA) | PalpitationsUnited States
-
University of North Carolina, Chapel HillCompletedPeriapical Periodontitis | Periapical Diseases | Endodontic Disease | Root Canal InfectionUnited States
-
Tokat Gaziosmanpasa UniversityCompletedPrimary Teeth | Pulpotomy | Pulpal Bleeding; StainingTurkey
-
Boston Scientific CorporationCompletedAtherosclerotic Lesions in the Aortorenal OstiumUnited States
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Bioventus LLCTerminated
-
Research Institute for Complex Problems of Cardiovascular...RecruitingAtrial FibrillationRussian Federation